Immunovaccine Raises Total of $11.2 Million in Public Offering and Private Placement

Announces Closing of Previously Announced Public Offering and Partial Exercise of Over-Allotment Option September 4, 2014 Immunovaccine Inc., a clinical stage vaccine and immunotherapy company, has closed the previously announced public offering (the “Offering”), raising gross proceeds of $9,514,543. Under the terms of the Offering, a total of 9,153,300 units (the “Units”) were issued at a price of $0.95 per …

Pfizer plans Animal-Health Unit IPO

According to Reuters, Pfizer Inc plans to separate its animal health unit into a stand-alone company, hoping to focus more intently on its core pharmaceuticals business.  Pfizer said on Thursday that preparations were under way for a public offering of a minority stake in the new animal health company, which would be called Zoetis. Ian Read, Pfizer's chief executive has …